- Home
- VTEX vs MDXG Comparison
VTEX vs MDXG Comparison
Compare VTEX & MDXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VTEX
- MDXG
- Stock Information
- Founded
- VTEX 1999
- MDXG 2006
- Country
- VTEX United Kingdom
- MDXG United States
- Employees
- VTEX N/A
- MDXG N/A
- Industry
- VTEX Computer Software: Prepackaged Software
- MDXG Biotechnology: Pharmaceutical Preparations
- Sector
- VTEX Technology
- MDXG Health Care
- Exchange
- VTEX Nasdaq
- MDXG Nasdaq
- Market Cap
- VTEX 1.2B
- MDXG 1.3B
- IPO Year
- VTEX 2021
- MDXG N/A
- Fundamental
- Price
- VTEX $6.43
- MDXG $7.98
- Analyst Decision
- VTEX Buy
- MDXG Strong Buy
- Analyst Count
- VTEX 4
- MDXG 5
- Target Price
- VTEX $9.75
- MDXG $12.00
- AVG Volume (30 Days)
- VTEX 706.5K
- MDXG 493.9K
- Earning Date
- VTEX 02-25-2025
- MDXG 02-26-2025
- Dividend Yield
- VTEX N/A
- MDXG N/A
- EPS Growth
- VTEX N/A
- MDXG N/A
- EPS
- VTEX 0.05
- MDXG 0.52
- Revenue
- VTEX $225,906,000.00
- MDXG $342,804,000.00
- Revenue This Year
- VTEX $16.70
- MDXG $9.56
- Revenue Next Year
- VTEX $17.63
- MDXG $9.19
- P/E Ratio
- VTEX $138.94
- MDXG $15.14
- Revenue Growth
- VTEX 21.27
- MDXG 10.93
- 52 Week Low
- VTEX $5.60
- MDXG $5.47
- 52 Week High
- VTEX $9.59
- MDXG $10.14
- Technical
- Relative Strength Index (RSI)
- VTEX 50.69
- MDXG 35.32
- Support Level
- VTEX $6.36
- MDXG $7.81
- Resistance Level
- VTEX $6.89
- MDXG $8.54
- Average True Range (ATR)
- VTEX 0.24
- MDXG 0.23
- MACD
- VTEX -0.01
- MDXG -0.05
- Stochastic Oscillator
- VTEX 35.42
- MDXG 18.09
About VTEX VTEX
Vtex provides a software-as-a-service digital commerce platform for enterprise brands and retailers. Its platform enables customers to execute their commerce plan, including building online stores, integrating and managing orders across channels, and creating marketplaces to sell products from third-party vendors. It generates maximum revenues from Brazil followed by Latin America and the rest of the world.
About MDXG MiMedx Group Inc
MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are primarily targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, it sells allografts for ophthalmic surgery and dental applications through licenses to third parties.